Literature DB >> 10705218

CpG DNA as a Th1 trigger.

K Heeg1, S Zimmermann.   

Abstract

Over the last few years, it has been recognized that along with structural components and products of bacteria, bacterial DNA is also capable of signaling infectious danger to cells of the innate immune system. Particular DNA sequences (CpG motifs), which are abundant in prokaryotic (bacterial) but not in mammalian DNA, cause the activation and stimulation of immune cells. Research has been catalyzed by the finding that certain synthetic oligodeoxynucleotides mimic the action of bacterial DNA. Immunostimulation induced by bacterial DNA or synthetic oligonucleotides not only contributes to our knowledge of the pathogen-host interrelationship during infection, but can also be used therapeutically to condition or modify ongoing immune responses of the adaptive immune system. Accordingly, CpG motifs have been used as vaccine adjuvants as well as instructing agents to selectively induce Th1-dominated immune responses. Hence, CpG motifs might be used in the future as adjuvants and/or immunomodulatory agents to treat or prevent undesired Th2-dominated immune responses, such as allergy. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10705218     DOI: 10.1159/000024303

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  18 in total

1.  Oral administration of CpG-ODNs suppresses antigen-induced asthma in mice.

Authors:  K Kitagaki; T R Businga; J N Kline
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

2.  Development of a poly (lactic-co-glycolic acid) particle vaccine to protect against house dust mite induced allergy.

Authors:  Vijaya B Joshi; Andrea Adamcakova-Dodd; Xuefang Jing; Amaraporn Wongrakpanich; Katherine N Gibson-Corley; Peter S Thorne; Aliasger K Salem
Journal:  AAPS J       Date:  2014-07-01       Impact factor: 4.009

3.  Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model.

Authors:  Karen A Near; Anthony W Stowers; Dragana Jankovic; David C Kaslow
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  DNA from protozoan parasites Babesia bovis, Trypanosoma cruzi, and T. brucei is mitogenic for B lymphocytes and stimulates macrophage expression of interleukin-12, tumor necrosis factor alpha, and nitric oxide.

Authors:  L K Shoda; K A Kegerreis; C E Suarez; I Roditi; R S Corral; G M Bertot; J Norimine; W C Brown
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

5.  Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif.

Authors:  C M Leutenegger; F S Boretti; C N Mislin; J N Flynn; M Schroff; A Habel; C Junghans; S A Koenig-Merediz; B Sigrist; A Aubert; N C Pedersen; B Wittig; H Lutz
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  [Immunostimulatory CpG oligodeoxynucleotides (CpG-ODN) in an orthotopic murine transitional cell carcinoma (TCC) model. Effect on local cytokine expression].

Authors:  P J Olbert; A J Schrader; R Hofmann; A Hegele
Journal:  Urologe A       Date:  2008-09       Impact factor: 0.639

7.  Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.

Authors:  Weiwen Jiang; Henry J Baker; Bruce F Smith
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

8.  Protection of chickens against Escherichia coli infections by DNA containing CpG motifs.

Authors:  Susantha Gomis; Lorne Babiuk; Dale L Godson; Brenda Allan; Tannis Thrush; Hugh Townsend; Philip Willson; Edwin Waters; Rolf Hecker; Andrew Potter
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

9.  Systemic Th1 immunization of mice against Helicobacter pylori infection with CpG oligodeoxynucleotides as adjuvants does not protect from infection but enhances gastritis.

Authors:  Frank Sommer; Henning Wilken; Gerhard Faller; Michael Lohoff
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

10.  Maternal and newborn immunization with a human immunodeficiency virus-1 immunogen in a rodent model.

Authors:  Ronald B Moss; Jay R Savary; Jocelyn P Diveley; Fred Jensen; Dennis J Carlo
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.